| Time | Session |
|---|---|
|
09:30
09:55
|
A New Horizon in ILD Treatment: Looking Beyond Nintedanib and Pirfenidone
|
|
09:55
10:20
|
|
|
10:20
10:45
|
The 2025 ATS/ERS Classification and Implications in Clinical Practice
|
|
10:45
11:00
|
Q&A
|